|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
PolysacDB ID | 2410 |
Carbohydrate Name | Type 1b polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Streptococcus Group B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | A mixture composed of equal parts of the vaccine suspensions of strains H36B (type Tb), 18RS21 (type II), and 1073 (nontypeable) |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab SMB19 |
Antibody Type Class | IgM |
Assay System | ELISA, indirect immunofluorescence |
Cross Reactivity | This Mab reacted specifically with the sialylated form of the type 1b polysaccharide. This Mab cross-reacts with some oligosaccharides in human milk and certain fetal antigens |
Proposed Epitope | Sialyllacto-N-tetraose residues seemed to be the immunodominant epitope |
IEDB Epitope | N/A |
Proposed Utility | This Mab will help in the development of appropriate vaccines against GBS that would include the possibility of inducing major cross-reactions with human glycoconjugates |
Curator ID | AA + AS |
Date of Curation | 02-05-2011 |
References | 1548081 |
PolysacDB ID | 2411 |
Carbohydrate Name | Type 1b polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe Name | Streptococcus Group B (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed Function | N/A |
Antigenic Nature | H36B vaccine that had been treated with 2 N acetic acid at 80°C for 10 min to largely desialylate the type lb polysaccharide. |
Carrier Name | Nil |
Conjugate Method | Nil |
Antibodies | Mab SIbD2 |
Antibody Type Class | IgM |
Assay System | ELISA, indirect immunofluorescence |
Cross Reactivity | This Mab reacted specifically with the de-sialylated form of the type 1b polysaccharide. This Mab cross-reacts with some oligosaccharides in human milk and certain fetal antigens |
Proposed Epitope | Lacto-N-tetraose residues seemed to be the immunodominant epitope |
IEDB Epitope | N/A |
Proposed Utility | This Mab will help in the development of appropriate vaccines against GBS that would include the possibility of inducing major cross-reactions with human glycoconjugates |
Curator ID | AA + AS |
Date of Curation | 03-05-2011 |
References | 1548081 |
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |